Zimmer Biomet Holdings Inc reported financial results for the quarter ended March 31, 2022. The Company reported first quarter net sales from continuing operations of $1.663 billion, an increase of 3.9% over the prior year period, and an increase of 6.8% on...
Zimmer Biomet Holdings Inc releases WalkAI, a dynamic artificial intelligence (AI) model that identifies patients who are predicted to have a lower gait speed outcome at 90 days after hip or knee surgery. WalkAI, reportedly the company’s first AI-based solution,...
